RETRACTED ARTICLE: GPR39 agonist TC-G 1008 ameliorates IL-1β-induced chondrocyte senescence

Abstract

We, the Editors and Publisher of the journal  Artificial Cells, Nanomedicine, and Biotechnology, have retracted the following article:

Huading Lu, Dawei Wang, Huizi Li, Junlong Zhong, Yimin Lin, Xianghe Xu & Bin Wang (2019) GPR39 agonist TC-G 1008 ameliorates IL-1β-induced chondrocyte senescence. Artificial Cells, Nanomedicine, and Biotechnology, 47(1), 2612–2617, DOI: 10.1080/21691401.2019.1626405

Since publication, the authors found that they were unable to obtain the same results following the performance of further experiments. As this directly impacts the reported results and conclusions the authors alerted the issue to the Editor and Publisher and all have agreed to retract the article to ensure correction of the scholarly record.

We have been informed in our decision-making by our policy on publishing ethics and integrity and the COPE guidelines on retractions.

The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as ‘Retracted’.

View retraction statement:

Statement of Retraction